Section Navigation
Media
Breadcrumb Navigation
Examples of new Linkage Infrastructure, Equipment and Facilities Projects in 2012 - Queensland
LIEF Projects totalling $3 807 000 covering 10 projects
The University of Queensland
Humanities in the digital age: infrastructure for Australian literary studies, publishing studies, and Aboriginal and Torres Strait Islander studies (LE120100106)
Summary: AustLit is a comprehensive digital resource providing quality, searchable information for researchers, teachers, students and the general public in the broadly defined areas of Australian literature and print culture. New funding will support enhanced content creation and research capacity and the transition of AustLit to an open access platform.
Chief Investigator: Professor David J Carter
ARC funding: $270 000
Griffith University
Bioaffinity mass spectrometry infrastructure to identify small molecules binding to therapeutic targets (LE120100170)
Summary: The development of anti-infective therapies is challenging because the underlying biology and biochemistry of pathogen virulence is not yet completely understood. This mass spectrometer facility will be used to identify small molecules suited for development into new therapies for malaria, tuberculosis and HIV.
Chief Investigator: Professor Ronald J Quinn
ARC funding: $580 000
The University of Queensland
A high-throughput screening and sequencing facility for single cell genomics (LE120100025)
Summary: Genomics has revolutionised biology, but for most micro-organisms this revolution has not arrived because very few can be grown in pure culture. The single cell genomics facility will address this major bottleneck by allowing as little as a single cell in a clinical or environmental setting to be sequenced, thereby accelerating new discoveries and outcomes.
Chief Investigator: Professor Philip Hugenholtz
ARC funding: $380 000
The University of Queensland
Overcoming membrane protein research roadblocks: A Queensland facility for membrane protein production and crystallisation (LE120100128)
Summary: Many drugs target specialised molecules called membrane proteins that reside at the interface between cells and the cells' environment. This membrane protein production facility will address significant challenges in the production and analysis of membrane proteins which will enable a better understanding of how they function and provide a platform for the design of new and better drugs.
Chief Investigator: Professor Jennifer L Martin
ARC funding: $237 000
